Brain, skull base, pituitary and spine tumors, functional brain mapping, minimally invasive endoscopy, microsurgery and stereotactic radiosurgery
Dr. Yaron Moshel is co-director of the Gerald J. Glasser Brain Tumor Center at Atlantic Health System’s Overlook Medical Center in Summit and part of the neurosurgical team at ANS in Morristown. He is also Clinical Assistant Professor of Neurosurgery at NYU Langone Medical Center.
Dr. Moshel is one of a select few surgeons who specialize in removing deep-seated brain tumors using technology that includes computer-guided navigation, awake intraoperative brain mapping, endoscopy, and microsurgery. Dr. Moshel is a vital part of Overlook Medical Center’s CyberKnife Program making it the largest CyberKnife Program in the tri-state region for the treatment of brain tumors. Dr. Moshel is also actively involved in advancing the treatment of brain tumors and actively participates in national multicenter clinical trials, most recently working with an autologous dendritic cell vaccine and on a retroviral vaccine trial for recurrent brain tumors.
Previously Assistant Professor of Neurosurgery at Thomas Jefferson University Hospital in Philadelphia, Dr. Moshel’s clinical interests and neurosurgical abilities extend beyond the treatment of brain tumors. He is experienced in the surgical approaches for skull base and spine tumors and in endoscopic transnasal surgery for pituitary and skull base lesions. His practice also encompasses the surgical treatment of epilepsy and minimally invasive treatment of trigeminal neuralgia.
Dr. Moshel received his Bachelor of Science with Honors from New York University and his M.D. and Ph.D. degrees from State University of New York in Brooklyn, NY. He was elected into the Alpha Omega Alpha (AOA) honor society and was the graduate school class valedictorian. His residency and Chief residency training in Neurosurgery were completed at New York University Medical Center and Bellevue Hospital Center in NY, New York. Dr. Moshel also completed advanced fellowship training in Neuro-Oncology, Stereotactic and Skull Base Surgery at New York University Medical Center. He further completed a research fellowship in Minimally Invasive Endoscopic Skull Base Surgery at New York Presbyterian Hospital/Weill-Cornell Medical Center.
Dr. Moshel is Board Certified by the American Board of Neurological Surgeons and he is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, North American Skull Base Society, AANS/CNS Joint Section on Tumors and Joint Section on Disorders of the Spine. He is actively involved in the training and mentoring of neurosurgical residents and serves as a reviewer for the Scientific Program Committee of the AANS Tumor Section. Additionally, Dr. Moshel has visited with several internationally renowned neurosurgeons and received numerous awards for his academic excellence and neurosurgical research including grant support from the American Cancer Society. As an active contributor to neurosurgical research, he has published many scholarly articles in the Journal of Neurosurgery, Neurosurgery and Epilepsia. He has also authored several book chapters on advances in stereotactic and minimally invasive spine and brain surgery.
Dr. Moshel is actively involved in the ANS Center for Hope brain tumor support group and his most important daily focus is on patient care. He has been recognized for his unwavering commitment and dedication to his patients and strives to further cancer treatments with them in mind.
New Vaccine Prolongs Life for Glioblastoma Patients
A major phase III clinical trial has found that DCVax®-L, a dendritic cell brain tumor vaccine, can prolong the lives of patients diagnosed with new or recurrent glioblastomas.
Stereotactic Radiosurgery Is on the Rise: Why a Growing Population of Patients with Brain Metastases Are Candidates for CyberKnife®
CyberKnife has completely changed the way metastatic brain tumors are treated by administering radiation only where it’s needed – and not where it’s not. Not only is CyberKnife a highly eﬀective therapy for the treatment of brain metastases, its precision spares healthy brain tissue from radiation exposure and the neurocognitive damage it can cause.
Beating Metastatic Brain Cancer with Surgery and CyberKnife
“You are disease-free in the brain.” Hearing these words nearly a year after discovering kidney cancer had spread to his brain brought 56-year-old Edward Battaglia to tears. This triumph was his latest victory in a cancer journey that spans more than a decade.
Dr. John J. Knightly, Dr. Yaron A. Moshel, Dr. Michael E. Rudman and Dr. Richard P. Winne, Jr. Named 2021 Jersey Choice Top Doctors
In its annual Top Docs listing, New Jersey Monthly has named Altair Health’s Dr. John J. Knightly, Dr. Yaron A. Moshel, Dr. Michael E. Rudman and Dr. Richard P. Winne, Jr. 2021 Jersey Choice Top Doctors.
Fluorescent imaging is Lighting the Way
The Gerald J. Glasser Brain Tumor Center is one of the first providers in New Jersey to harness the power of fluorescent imaging to treat brain tumors.
Neurosurgery Saved Me From Going Blind
Basil Figliano, an electrician from Bridgewater, New Jersey, had perfect vision his entire life. In fact, he went for his first ophthalmologist appointment at the age of 56. Over the next few months, Basil felt his vision getting drastically worse.
Local Dad’s Journey to Survive
Chatham resident Mark Boyland went from brain tumor-induced seizures to white water sports in seven weeks.
Former Marine Battles Brain Cancer with Life-Saving Tumor Treatment
Ray Aponte braved the harrowing experiences of war. Yet, he was never more terrified than when he learned he had a malignant brain tumor – one that, if he survived, would threaten his ability to talk or move for the rest of his life. See how Ray’s awake brain surgery and personalized targeted drug treatments are enabling him to live his life to the fullest.
Treating Recurrent Gliomas with Intense Precision … and Hope
While there is no cure for gliomas – and they are challenging to manage because they grow within the brain and inevitably reoccur – there are very effective treatments.
Glioblastoma: Is One of Our Current Clinical Trials Right for You?
At the Gerald J. Glasser Brain Tumor Center, two clinical trials to evaluate the potential role of immunotherapy – specifically immune checkpoint inhibitors – in patients with glioblastoma are currently underway.
Combining the Best in Medical and Non-Medical Care
At the Glasser Brain Tumor Center, our multidisciplinary team – including our social work navigator – work closely with patients and their families, providing appointment scheduling, referrals and other support as well as the counseling that enables emotional and mental wellbeing.
Revolutionizing the Removal of Complex Glioma Tumors
Removing gliomas as safely and completely as possible requires years of experience and a deep understanding of the brain’s three-dimensional anatomy and functional relationships. Today, this expertise is supported by technological advances that enable more precise, less-invasive tumor removal.
Two Foundations Support Patients, Families and the Gerald J. Glasser Brain Tumor Center
The Center for Hope Foundation and the Overlook Foundation provide patients, families and supporters with a way to make a difference in the lives of those impacted by brain tumors.
Dealing with the Side Effects of Chemotherapy
Chemotherapy … with all of its wondrous outcomes … can cause many side effects. What’s the best way to combat them? A combination of medical and holistic approaches can be very effective in relieving nausea, constipation, fatigue and low blood cell counts.
Top Lawyer Credits Health After Brain Surgery to NJ-Based Neurosurgical Care
“I don’t have time for this.” That was the first thought that crossed Mark Boyland’s mind when he was diagnosed with a skull base brain tumor. With a high-powered legal career, hobbies like waterskiing and paddle boarding, and an equally active family at home, it was hard for Mark to fathom slowing down.
Molecular Testing Guides Precise Treatment Options
For decades, examining a biopsy under the microscope is where the diagnosis of a brain tumor began ... and ended. However – since different tumors often appear to be alike under the microscope – the precise diagnosis was often questionable, leaving doctors and patients unsettled. Today’s current approach goes much further thanks to molecular testing.
Dr. John J. Knightly, Dr. Yaron A. Moshel, Dr. Michael E. Rudman and Dr. Richard P. Winne, Jr. Named 2020 Jersey Choice Top Doctors
In its annual Top Docs listing, New Jersey Monthly has named ANS | Altair Health’s Dr. John J. Knightly, Dr. Yaron A. Moshel, Dr. Michael E. Rudman and Dr. Richard P. Winne, Jr. 2020 Jersey Choice Top Doctors.
When is Neck Pain More than Just Stress?
After being told her neck pain was due to stress, 34-year-old Erika Kiel discovered she had a malignant tumor in her brainstem and made an incredible recovery following neurosurgery.
Battling a Brain Tumor, Single Mother Finds Neurosurgeon Who Helps Her Put Kids First
Susan Pisarchik, 48, discovered her symptoms weren’t just signs of middle age and that she needed to undergo complex brain surgery at the base of her skull – quickly.